“All legal means will be used” in Italy’s re approval of late delivery of vaccines by pharmaceutical companies

Source Title: “all legal means will be used” in Italy’s re approval of late delivery of vaccines by pharmaceutical companies

Xinhua news agency, Beijing, January 24 (reporter Zheng Haoning) – Italian Prime Minister Giuseppe & middot; Conte warned on the 23rd that pharmaceutical companies would delay the delivery of the new vaccine, and Italy would “use all possible legal means” to protect its rights, just like “what we are ready to do to Pfizer and biotechnology company”;. Coulter wrote on social media that the Italian vaccination plan is based on the contracts agreed between major pharmaceutical companies and the European Commission, which is a serious breach of contract and unacceptable;. on January 18, in Rome, Italy, Italian Prime Minister Conte delivered a speech in the house of Representatives. (Xinhua News Agency) The new crown vaccine jointly developed by Pfizer Pharmaceutical Co., Ltd. of the United States and new biotechnology company of Germany has been approved by the European Union. However, Pfizer slowed down the speed of vaccine delivery on the ground that its pharmaceutical factory in Belgium needs to be transformed to improve production capacity, including reducing the number of vaccines delivered to Italy by 29% from 18 this month, and did not specify how long the supply reduction will last. Italy and Poland have previously warned that Pfizer could be taken to court. Similar to Pfizer, British Pharmaceutical Company AstraZeneca said on the 22nd that it will also reduce the number of new vaccines delivered to the EU due to the reduction of production capacity of a factory. AstraZeneca did not disclose the reason for the decline. Italy is promoting the vaccination of two new vaccines approved by the European Union, which are Pfizer’s vaccine and Modena’s vaccine. The European drug administration is scheduled to decide 29 days ago whether to approve the new crown vaccine jointly developed by AstraZeneca and Oxford University. If AstraZeneca also delays the delivery of the vaccine, Italy could get 3.4 million doses in the first quarter of this year, instead of the 8 million doses previously expected, Conte said. on December 28, 2020, medical staff prepare for the new coronal vaccine in a hospital in Rome, Italy. (Xinhua News Agency) Franco & middot; Locatelli, President of the Italian higher Health Council, said on the 23rd that if the problem of vaccine supply can not be solved for a long time, Italy will have to reconsider the whole vaccination plan. Due to the shortage of vaccine supply, Italy has been forced to reduce the number of daily vaccinations by more than two-thirds, from a maximum of about 90000 doses a day two weeks ago to 20000 to 25000 doses, Locatelli said. Italy has received about 1.31 million doses of the vaccine, and nearly 43000 people have completed two doses of the vaccine, Reuters reported.

Xinhua news agency, Beijing, January 24 (reporter Zheng Haoning) – Italian Prime Minister Giuseppe & middot; Conte warned on the 23rd that pharmaceutical companies would delay the delivery of the new vaccine, and Italy would “use all possible legal means” to protect its rights, just like “what we are ready to do to Pfizer and biotechnology company”;.

Coulter wrote on social media that the Italian vaccination plan is based on the contracts agreed between major pharmaceutical companies and the European Commission, which is a serious breach of contract and unacceptable;.

On January 18, in Rome, Italy, Italian Prime Minister Condoleezza Conte delivered a speech in the house of Representatives. (Xinhua News Agency)

The new crown vaccine jointly developed by Pfizer Pharmaceutical Co., Ltd. of the United States and new biotechnology company of Germany has been approved by the European Union. However, Pfizer slowed down the speed of vaccine delivery on the ground that its pharmaceutical factory in Belgium needs to be transformed to improve production capacity, including reducing the number of vaccines delivered to Italy by 29% from 18 this month, and did not specify how long the supply reduction will last. Italy and Poland have previously warned that Pfizer could be taken to court.

Similar to Pfizer, British Pharmaceutical Company AstraZeneca said on the 22nd that it will also reduce the number of new vaccines delivered to the EU due to the reduction of production capacity of a factory. AstraZeneca did not disclose the reason for the decline.

Italy is promoting the vaccination of two new vaccines approved by the European Union, which are Pfizer’s vaccine and Modena’s vaccine. The European drug administration is scheduled to decide 29 days ago whether to approve the new crown vaccine jointly developed by AstraZeneca and Oxford University.

If AstraZeneca also delays the delivery of the vaccine, Italy could get 3.4 million doses in the first quarter of this year, instead of the 8 million doses previously expected, Conte said.

On December 28, 2020, medical staff prepare for the new crown vaccination at a hospital in Rome, Italy. (Xinhua News Agency)

Franco & middot; Locatelli, President of the Italian higher Health Council, said on the 23rd that if the problem of vaccine supply cannot be solved for a long time, Italy will have to reconsider the whole vaccination plan.

Due to the shortage of vaccine supply, Italy has been forced to reduce the number of daily vaccinations by more than two-thirds, from a maximum of about 90000 doses a day two weeks ago to 20000 to 25000 doses, Locatelli said.

Italy has received about 1.31 million doses of the vaccine, and nearly 43000 people have completed two doses of the vaccine, Reuters reported.

留下评论

您的电子邮箱地址不会被公开。 必填项已用*标注